2.1. Study Design
overweight or obesity
This was a randomized, double-blind, and placebo-controlled trial involving adult men and women with overweight or obesity (BMI ≥ 25). After the initial screening, twenty-eight participants (mean BMI: 29.4 ± 4.7) were randomly allocated (1:1) to the supplementation group (